BCLI: Total dodolan perusahaan BrainStorm Cell Therapeutics
Gross sales revenue for Brainstorm Cell (BCLI) demonstrates a trend where the parameter value equals 0.00. Brainstorm Cell (BCLI) revenues are based on the success of NurOwn therapy for ALS and FDA approval. High costs for testing and production sterility create a significant barrier to entry. However, regulatory complexities regarding drug registration temporarily hinder the formation of a sustainable competitive advantage for the business.
Rincian analitis perusahaan BrainStorm Cell Therapeutics (BCLI)
- nilai pasar lan prakiraan target analis:
- informasi kapitalisasi pasar:
- indikator kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Brainstorm Cell|BCLI - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Brainstorm Cell Therapeutics Inc.|BCLI - Gunggung utang perusahaan|Utang marang nilai buku Brainstorm Cell Therapeutics Inc.|BCLI - Utang jangka dawa perusahaan|Utang jangka cendhak BrainStorm Cell Therapeutics|Likuiditas cepet brainstorm-cell.com
- data bathi bisnis lan rasio investasi:
BCLI - Bathi resik perusahaan|Bathi sing dikarepake Brainstorm Cell|BCLI - Pangali P/E|Rega marang bathi mangsa ngarep brainstorm-cell.com|BCLI - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Brainstorm Cell Therapeutics Inc.|BCLI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan BrainStorm Cell Therapeutics|BCLI - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan brainstorm-cell.com|BCLI - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Brainstorm Cell
- indikator volume dodolan lan pendapatan:
Ringkesan analisis perusahaan:BCLI BrainStorm Cell Therapeutics Inc.
The daily sales chart for Brainstorm Cell (BCLI) filters out market noise, accurately capturing revenue inflows from product sales and allowing investors to identify long-term expansion trends or the risk of asset overvaluation. For Brainstorm Cell (BCLI), this sales trend reflects the commercial success of implementing patented cellular technologies amidst stringent FDA regulation and the high cost of clinical trials.
Pesaing wigati
Biogen Idec (BIIB) - Pendapatan reged perusahaan|Dodolan perusahaan NBIX (Neurocrine Biosciences)|Total dodolan perusahaan RGC|Pendapatan perusahaan Axsome Therapeutics, Inc. AXSM|ACADIA Pharma (ACAD) - Total pendapatan perusahaan|XENE - Pendapatan perusahaan|Pendapatan dodolan perusahaan VKTX (Viking Therapeutics Corp)|Supernus Pharmaceuticals (SUPN) - Pendapatan perusahaan|Dodolan perusahaan catalystpharma.com|Dodolan perusahaan DNLI|HRMY: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan BHVN|Dodolan perusahaan Amylyx Corp AMLX|Pendapatan lan volume dodolan TRVI (Trevi Therapeutics)|praxismedicines.com (PRAX) - Total pendapatan perusahaan|AVXL - Pendapatan perusahaan|CBLL: Pendapatan perusahaan|Prothena Corporation PLC (PRTA) - Pendapatan perusahaan|ALEC (Alector) - Pendapatan perusahaan|ANNX (Annexon, Inc.) - Pendapatan lan volume dodolan|Pendapatan perusahaan OMER|Pendapatan lan volume dodolan NGNE|Dodolan perusahaan AC Immune S.A. ACIU|Pendapatan perusahaan Voyager Pharma VYGR|Neumora Corp - Pendapatan perusahaan|Scilex Holding Company - Pendapatan lan volume dodolan|Pendapatan reged perusahaan tevogen.com TVGN|alphacognition.com (ACOG) - Pendapatan perusahaan|Volume dodolan perusahaan CGTX|IKT (Inhibikase) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Cassava Pharma SAVA|Dodolan perusahaan ASRT (Assertio Holdings, Inc.)|Pendapatan lan volume dodolan coyatherapeutics.com (COYA)|Pendapatan perusahaan Vistagen VTGN|Pendapatan dodolan perusahaan OVID|ABOS - Pendapatan perusahaan|Total pendapatan perusahaan CervoMed Corporation|ATHE: Pendapatan lan volume dodolan|CLNN (Clene) - Pendapatan perusahaan|Pendapatan perusahaan PepGen Inc|JUNS: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RLMD|Pendapatan lan volume dodolan Annovis Bio Corporation (ANVS)|Pendapatan lan volume dodolan GRCE (Grace Therapeutics)|Pendapatan reged perusahaan fireflyneuro.com (AIFF)|KLTO - Pendapatan perusahaan|NRSN (NeuroSense Therapeutics) - Volume dodolan perusahaan|Reviva Pharmaceuticals Holdings (RVPH) - Pendapatan perusahaan|MTVA - Pendapatan reged perusahaan|Dodolan perusahaan NRXS|HSDT (Helius Medical Technologies Inc.) - Total dodolan perusahaan|Pendapatan perusahaan Passage Bio, Inc. (PASG)|NEUP - Total pendapatan perusahaan|Pendapatan perusahaan Minerva Neurosciences Corp NERV|Pendapatan dodolan perusahaan ATHA|ADXN - Pendapatan perusahaan|Alzamend Neuro, Inc. (ALZN) - Dodolan perusahaan|CYCN (cyclerion.com) - Dodolan perusahaan|Protagenic Therapeutics, Inc. - Pendapatan dodolan perusahaan|KTTA (Pasithea Therapeutics Corp) - Pendapatan lan volume dodolan|Dodolan perusahaan Cortigent Medical (CRGT)|Pendapatan lan volume dodolan ATXI|CARA - Total pendapatan perusahaan|Pendapatan perusahaan Chromocell Therapeutics Corp. CHRO|Eliem Therapeutics, Inc. - Pendapatan perusahaan|ITCI - Pendapatan perusahaan|LBPH: Pendapatan perusahaan|MRNS: Pendapatan lan volume dodolan|NKGN (nkgenbiotech.com) - Pendapatan perusahaan|NRBO (NeuroBo Pharmaceuticals, Inc.) - Pendapatan lan volume dodolan|Dodolan perusahaan Sage Therapeutics Inc. (SAGE)|Pendapatan perusahaan Neurotrope (SNPX)|Pendapatan perusahaan TRVN (Trevena Inc)|Pendapatan lan volume dodolan VIGL (Vigil Neuroscience, Inc.)|Pendapatan reged perusahaan Anew Medical Inc. (WENA)|CERE - Pendapatan perusahaan
